🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective open-label, uncontrolled, single-blind, pilot clinica...
Status
Completed
Location
University of Alberta
Start Date
2014-10
Trial ID
NCT02774239
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of one...
Status
Completed
Location
Kalifabougou MRTC Clinic
Start Date
2022-03-18
Trial ID
NCT05304611
All patients will receive the investigational medicinal product BP-SCIG 20%...
Status
Recruiting
Location
Municipal Non-Profit Enterprise "Cherkasy Regional Children's Hospital" of the Cherkasy Regional Council
Start Date
2025-12-17
Trial ID
NCT07346859
Treatments Being Tested
The purpose of the study is to develop a 20% subcutaneous immunoglobulin tr...
Status
Completed
Location
Medizinische Universität Wien / AHK Wien (General Hospital Vienna), Universitätsklinik für Kinder- und Jugendheilkunde
Start Date
2011-06-20
Trial ID
NCT01412385
This is a 52 week, single center, randomized, double-blind, placebo-control...
Status
Recruiting
Location
Hospital for Special Surgery
Start Date
2019-07-29
Trial ID
NCT03844061
Treatments Being Tested
Primary Objective: Study the effect of mild or moderate hepatic impairment...
Status
Completed
Location
Investigational Site Number 250001
Start Date
2012-09
Trial ID
NCT01670734
Treatments Being Tested
The objective of this study is to assess the efficacy, tolerability, safety...
Status
Completed
Location
Study site
Start Date
2007-09
Trial ID
NCT00542997
Treatments Being Tested
The purpose of this registry is to acquire safety data (including assessmen...
Status
Completed
Location
QuintilesIMS Plaza Building
Start Date
2015-12-04
Trial ID
NCT02556775
The purpose of this study is to evaluate the safety and tolerability of one...
Status
Completed
Location
Kenya Medical Research Institute (KEMRI) Center for Global Health Research (CGHR)
Start Date
2022-09-14
Trial ID
NCT05400655
This study evaluates the efficacy and safety of the addition of Firsekibart...
Status
Not Yet Recruiting
Location
Jiangxi Provincial Children's Hospital
Start Date
2026-08-01
Trial ID
NCT07686770
Treatments Being Tested